Rifalazil controlled release

Drug Profile

Rifalazil controlled release

Alternative Names: Rifalazil GR

Latest Information Update: 25 May 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ActivBiotics; Depomed
  • Class Antituberculars; Rifamycins
  • Mechanism of Action DNA-directed RNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Helicobacter infections

Most Recent Events

  • 30 Jun 2004 Discontinued - Preclinical for Helicobacter infections in USA (PO)
  • 07 Apr 2004 This compound is still in active development - (BioSquare-2004)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top